Fires and Biontech announced, Wednesday, that their vaccine against the emerging corona virus (Covid-19) is 100% effective in people between the ages of 12 and 15, according to the results of a clinical trial, so why is this wonderful news and important progress in addressing Corona?

The beginning was when Firees and Biontech said in a statement that the Phase III trials - which included 2,260 boys and girls in that category - "showed 100% efficacy and strong antibody responses."

Albert Burla, director general of the US pharmaceutical giant Pfizer Group, said that the testers will submit these data to the relevant authorities in the world, "with the hope that this age group will be vaccinated before the start of the next school year."

For his part, Chairman of the Board of Directors of German Biontech Laboratories Ugur Shaheen said that the results on boys and girls between 12 and 15 years "are very encouraging in light of the trends observed in the past weeks regarding the spread of the mutated version of the virus that was detected in Britain."

The Pfizer-Bionic vaccine was the first vaccine against Covid-19 to be approved for use in many western countries by the end of 2020, and the United States and the European Union allowed it to be used by those aged 16 years and over.

Will Pfizer run tests on younger children?

Yes, last week Pfizer and Biontek started clinical studies on children, and included a first group of children between the ages of 5 and 11 years, provided that a younger group (between two and five years old) will receive the first dose of the vaccine next week, as part of the study that will also cover children Between 6 months and 2 years.

Why is the success of the Corona vaccine in children is wonderful?

The vaccine will help protect children

According to the World Health Organization, the data indicates - so far - that children under the age of 18 years represent about 8.5% of the reported cases, with relatively few deaths compared to other age groups, and the disease is usually mild.

However, severe illness has been reported as well as adults, and pre-existing medical conditions have been suggested as a risk factor for developing severe illness and admission to intensive care in children.

So;

The vaccine will help reduce the risk of infection, and also develop complications in children.

According to the Qatar Biomedical Research Institute, infection with Covid-19 virus is not limited to adults and the elderly in our societies. On the contrary, reports indicate that the Covid-19 virus does affect children and newborns, and in some cases complications occur. Clinical risk.

According to current data, the clinical symptoms of children with Covid-19 virus are relatively lighter compared to adults and the elderly, however, some infected children need hospitalization and even intensive care.

The institute said that "a study on cases of Corona virus in children in emergency departments - conducted on 100 Italian children (under 18 years of age) - indicated that 21% of child patients were without symptoms, 58% of them had mild symptoms, and 19% were Symptoms are moderate, 1% had severe symptoms, and 1% were in a critical condition. Most of the children who were admitted to the hospital had previous medical conditions, such as lung disease or cardiovascular disease, or were suffering from immunosuppression.

The Qatar Institute added that it is surprising that since the beginning of the Covid-19 pandemic, many reports have appeared about young patients who have developed multiple cases of inflammation in the body parts with symptoms similar to toxic shock syndrome and Kawasaki disease.

According to the Mayo Clinic, toxic shock syndrome is a rare, life-threatening complication of certain bacterial infections.

Toxic shock syndrome is often caused by toxins produced by Staphylococcus aureus, but the condition may also be caused by toxins produced by Streptococcus bacteria.

Kawasaki syndrome causes inflammation in the walls of blood vessels, which weakens the coronary arteries, and may lead to aneurysms and heart attack.

In Italy and France, inflammatory infections in multiple devices were about 30 times higher during the pandemic compared to the period before the virus spread.

Most of these affected children were those who had tested positive for COVID-19 or had been specifically exposed to SARS-CoV-2 virus, and had serious immune complications that required intensive care;

This indicates a possible link between Covid-19 and the inflammatory state that affects multiple systems in the body.

According to the Qatar Institute, the World Health Organization has referred to cases associated with Covid-19, such as multisystem inflammatory syndrome, or pediatric multisystem inflammatory syndrome.

It has been shown that children with both syndromes have an immune response that affects the organs and blood vessels, and this inflammation may lead to heart damage.

The symptoms of these two syndromes also appear in the form of high fever that lasts more than 5 days, severe abdominal pain, vomiting, diarrhea, rash, changes in skin color, difficulty eating, drinking and breathing, and chest pain.

Symptoms may also include swollen and red hands and feet, red or cracked lips or tongue, and swollen lymph nodes in the neck.

The vaccine will help reduce the transmission of infection in children

According to the World Health Organization, because children generally suffer from milder disease and fewer symptoms, cases may sometimes go unnoticed.

Importantly, early data from studies indicate that infection rates among teens may be higher than younger children.

According to the Qatar Biomedical Research Institute, Covid-19 can infect children without the appearance of symptoms in many cases, and it is expected that these children will participate in the transmission of infection among members of society, especially given that Covid-19 manifests itself in this age group as an infection. They infect the upper respiratory tract and are more likely to be transmitted.

Giving the Corona vaccine to children will help reduce the transmission of infection among children, and thus reduce the transmission of infection from children to other groups of society, which are more susceptible to complications of the disease, such as patients with chronic diseases and the elderly.